Company intelligence / Profile preview

Front Line Medical Technologies

London, Ontario, Canada

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Front Line Medical Technologies' COBRA-OS® has demonstrated positive real-world results in controlling hemorrhage, particularly in trauma and obstetric settings, with rapid adoption in major trauma centers, military, and obstetric referral centers. It is CE-marked, Health Canada and FDA approved, and has been presented with real-world data for high-risk placenta accreta and major trauma settings.[2][4][13]

Therapeutic areas: Women's HealthHematology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Mermaid Medical (European distribution partner)

Beyond the preview

Go deeper on Front Line Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Front Line Medical Technologies.

Explore the full profile